Many stocks crumbled during the past few months as the Trump administration's on-and-off tariffs rattled the markets. The uncertainty regarding those policies broadly drove more investors toward safe ...

First quarter revenues for 2025 exceed all of last year’s revenue of the Company, showcasing ability to grow business fundamentals while in conjunction with other value-added activities, such as stock ...

We recently published a list of 30 Best AI Stocks to Buy According to Billionaires. In this article, we are going to take a ...

In this now-shaky macro environment, those who wish to buy stock may want to start by looking for companies that might not be ...

Viper Energy targets low-cost, fast-developing acreage with strong operators and resilient income potential. Learn why VNOM ...

As economic uncertainty makes markets feel like a financial rollercoaster designed by a prankster, investors are flocking to ...

XOMA Royalty is a biotech royalty aggregator focused on early to mid-stage clinical assets and late-stage commercial ones. It ...

Osisko recorded preliminary revenues from royalties and streams of $54.9 million during the first quarter and preliminary cost of sales (excluding depletion) of $1.6 million, resulting in a quarterly ...

April has gotten off to about as bad a start as a month can have in the stock market. The S&P 500 plunged more than 10% in a ...

Nike is losing market share to companies that focus on poorer customers and to companies that produce more ethical and ...

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...